ALPHAMAB-B: (1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
Apr 23 07:44 ET
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - UPDATES ON RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 AACR ANNUAL MEETING
Apr 9 18:05 ET
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 3 04:42 ET
ALPHAMAB-B: (1) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION; AND (2) RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT
Apr 2 08:55 ET
ALPHAMAB-B: CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT
Mar 28 09:56 ET
ALPHAMAB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 28 09:50 ET
ALPHAMAB-B: DATE OF BOARD MEETING
Mar 18 04:33 ET
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 5 06:00 ET
ALPHAMAB-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 6 03:47 ET
ALPHAMAB-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 6 03:45 ET
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 6 03:33 ET
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - LICENSE AGREEMENT WITH 3D MEDICINES AND GLENMARK FOR KN035
Jan 24 19:05 ET
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 4 06:00 ET
ALPHAMAB-B: EXTENSION OF WAIVER REGARDING THE QUALIFICATION AND EXPERIENCE OF A JOINT COMPANY SECRETARY
Dec 19, 2023 05:31 ET
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - A PHASE I/II CLINICAL TRIAL OF JSKN033 FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED OR METASTATIC SOLID TUMORS WAS APPROVED IN AUSTRALIA
Dec 7, 2023 23:05 ET
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN026 AT THE SABCS 2023
Dec 6, 2023 18:21 ET
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 5, 2023 08:58 ET
ALPHAMAB-B: Next Day Disclosure Return
Nov 28, 2023 07:34 ET
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - CLARIFICATION
Nov 24, 2023 07:27 ET
ALPHAMAB-B: INSIDE INFORMATION ANNOUNCEMENT - PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 IN AUSTRALIA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS
Nov 15, 2023 23:24 ET
No Data
No Data